PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Zonisamide
Presentation Product Chemical substance Chapter Items dispensed
Zonisamide 100mg capsules
0408010ADAAAAAA
Zonisamide Zonisamide Central Nervous System 24,028
Zonisamide 50mg capsules
0408010ADAAACAC
Zonisamide Zonisamide Central Nervous System 16,966
Zonisamide 25mg capsules
0408010ADAAABAB
Zonisamide Zonisamide Central Nervous System 7,774
Zonisamide 100mg/5ml oral suspension
0408010ADAAAGAG
Zonisamide Zonisamide Central Nervous System 895
Zonisamide 50mg/5ml oral suspension
0408010ADAAAEAE
Zonisamide Zonisamide Central Nervous System 212
Zonisamide 25mg/5ml oral suspension
0408010ADAAAFAF
Zonisamide Zonisamide Central Nervous System 18
Zonisamide 50mg/5ml oral solution
0408010ADAAADAD
Zonisamide Zonisamide Central Nervous System 18
Zonisamide 20mg/ml oral suspension sugar free
0408010ADAAAHAH
Zonisamide Zonisamide Central Nervous System 3
Zonisamide 200mg capsules
0408010ADAAAIAI
Zonisamide Zonisamide Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.